title: [Surgical controversy. Limiting postoperative scarring].
abstract: Postoperative follow-up of glaucoma surgery must be rigorous and carried out over the long term. Data acquired on the make-up of the filtering bleb justifies using postoperative anti-inflammatory drugs, even if the eye is clinically quiet. When using antimetabolites, the risk factors for failure must be well known and either 5-fluorouracile or mitomycin should be chosen depending on the level of risk of scarring. Their use in needle revision must be adapted case by case. anti-TGF-beta-2 antibody, currently being investigated, may prove advantageous in the very near future.
authors.affiliation: Institut du glaucome, Fondation Hôpital Saint-Joseph, 185 rue Raymond-Losserand, 75674 Paris Cedex 14.
authors.forename: Y
authors.initials: Y
authors.lastname: Lachkar
mesh_terms: D002921:Cicatrix / Q000517:prevention & control*; D005901:Glaucoma / Q000601:surgery*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*